Gene: BMPER
Official Full Name: BMP binding endothelial regulatorprovided by HGNC
Gene Summary: This gene encodes a secreted protein that interacts with, and inhibits bone morphogenetic protein (BMP) function. It has been shown to inhibit BMP2- and BMP4-dependent osteoblast differentiation and BMP-dependent differentiation of the chondrogenic cells. Mutations in this gene are associated with a lethal skeletal disorder, diaphanospondylodysostosis. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19404 | BMPER Knockout cell line (HeLa) | Human | BMPER | 1:3~1:6 | Negative | Online Inquiry |
KO19405 | BMPER Knockout cell line (A549) | Human | BMPER | 1:3~1:4 | Negative | Online Inquiry |
BMPER Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology, providing researchers with genetically engineered models that have had the BMPER gene specifically inactivated. BMPER, or Bone Morphogenetic Protein-Energy Regulator, plays a significant role in the regulation of bone morphogenetic protein signaling pathways, which are essential for various cellular processes including development, cell differentiation, and tissue homeostasis. By utilizing these knockout cell lines, scientists can investigate the downstream effects of BMPER in various biological contexts and better understand its involvement in disease mechanisms and developmental biology.
The function of BMPER is crucial in modulation of BMP signaling, which is integral to bone formation, vascularization, and the progression of certain diseases. The BMPER Gene Knockout Cell Lines allow researchers to study the functional consequences of BMPER loss, enabling deeper insights into cellular signaling and the pathophysiology of conditions like osteoporosis and cancer. Furthermore, these cell lines can serve as a valuable platform for drug discovery and development, offering a realistic model for testing therapeutic interventions aimed at BMP-mediated pathways.
What sets our BMPER Gene Knockout Cell Lines apart from standard cell lines is the precision of the gene knockout achieved through CRISPR-Cas9 technology, ensuring the reliability and reproducibility of experimental outcomes. The specificity of this gene edit minimizes off-target effects commonly associated with traditional knockout methods, providing researchers with confidence in their data while saving valuable time in experimental design and validation.
For researchers and clinicians, the BMPER Gene Knockout Cell Lines offer an unparalleled opportunity to advance our understanding of BMPER-related functions in health and disease. These cell lines unlock new avenues for exploration that could contribute significantly to scientific knowledge and could accelerate the development of innovative therapeutic strategies.
As a leader in the field of genetic engineering and cellular models, our company is committed to providing state-of-the-art biological products that empower researchers to push the boundaries of scientific discovery. With our expertise in cell line development and characterization, we ensure that our BMPER Gene Knockout Cell Lines are of the highest quality, supporting your research goals efficiently and effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.